Literature DB >> 18079035

Depressive symptoms and baseline prefrontal EEG alpha activity: a study utilizing Ecological Momentary Assessment.

Katherine M Putnam1, Lauren B McSweeney.   

Abstract

Prefrontal cortex (PFC) electroencephalography (EEG) alpha asymmetry has been found in individuals with major depression. However, EEG activity has never been examined in regard to specific depressive symptoms. We examine the relationship between resting baseline PFC alpha activity and both rumination and self-esteem in a depressed outpatient group (N=6) and a healthy control group (N=7) using high-density EEG sampling and multiple longitudinal self report measures, i.e. Ecological Momentary Assessment (EMA). Symptom measures were collected five times daily for 7 days, i.e. 35 assessments. Using a mixed-level analysis, significant Group x Hemisphere interactions for PFC sites and both rumination and self-esteem were found. Within the depressed group, lower bilateral PFC activity predicted higher levels of rumination, and lower right PFC activity predicted higher levels of self-esteem. There were no significant effects for the control group. Results indicate that specific symptoms of depression are uniquely associated with patterns of PFC EEG alpha activity.

Entities:  

Mesh:

Year:  2007        PMID: 18079035     DOI: 10.1016/j.biopsycho.2007.10.010

Source DB:  PubMed          Journal:  Biol Psychol        ISSN: 0301-0511            Impact factor:   3.251


  19 in total

1.  User profiles of an electronic mental health tool for ecological momentary assessment: MEmind.

Authors:  María Luisa Barrigón; Sofian Berrouiguet; Juan José Carballo; Covadonga Bonal-Giménez; Pablo Fernández-Navarro; Bernadette Pfang; David Delgado-Gómez; Philippe Courtet; Fuensanta Aroca; Jorge Lopez-Castroman; Antonio Artés-Rodríguez; Enrique Baca-García
Journal:  Int J Methods Psychiatr Res       Date:  2017-03-09       Impact factor: 4.035

2.  Tendency to ruminate and anxiety are associated with altered alpha and beta oscillatory power dynamics during memory for contextual details.

Authors:  Nicole A Forner-Phillips; Caitlin Mills; Robert S Ross
Journal:  Cogn Affect Behav Neurosci       Date:  2020-08       Impact factor: 3.282

3.  Psychosocial Functioning Among Inmates in Prison-Based Drug Treatment: Results from Project BRITE.

Authors:  William M Burdon; Jef St De Lore; Jeff Dang; Umma S Warda; Michael L Prendergast
Journal:  J Exp Criminol       Date:  2013-03-01

4.  Resting-state EEG delta power is associated with psychological pain in adults with a history of depression.

Authors:  Esther L Meerwijk; Judith M Ford; Sandra J Weiss
Journal:  Biol Psychol       Date:  2015-01-17       Impact factor: 3.251

5.  The neural basis of unwanted thoughts during resting state.

Authors:  Simone Kühn; Marie-Anne Vanderhasselt; Rudi De Raedt; Jürgen Gallinat
Journal:  Soc Cogn Affect Neurosci       Date:  2013-08-07       Impact factor: 3.436

Review 6.  The nucleus accumbens: a target for deep brain stimulation in resistant major depressive disorder.

Authors:  Cecilia Nauczyciel; Suzanne Robic; Thibaut Dondaine; Marc Verin; Gabriel Robert; Dominique Drapier; Florian Naudet; Bruno Millet
Journal:  J Mol Psychiatry       Date:  2013-10-23

7.  Sensorimotor modulation of mood and depression: in search of an optimal mode of stimulation.

Authors:  Resit Canbeyli
Journal:  Front Hum Neurosci       Date:  2013-07-30       Impact factor: 3.169

8.  A clinical case study of the use of ecological momentary assessment in obsessive compulsive disorder.

Authors:  P J Matt Tilley; Clare S Rees
Journal:  Front Psychol       Date:  2014-04-17

9.  Decreased interhemispheric coordination in treatment-resistant depression: a resting-state fMRI study.

Authors:  Wenbin Guo; Feng Liu; Zhimin Xue; Keming Gao; Zhening Liu; Changqing Xiao; Huafu Chen; Jingping Zhao
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

Review 10.  The neural basis of optimism and pessimism.

Authors:  David Hecht
Journal:  Exp Neurobiol       Date:  2013-09-30       Impact factor: 3.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.